Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2017-08-03

FDA Approved: GEMCITABINE — Original Application (Accord Healthcare Inc.)

View source ↗

Summary

FDA approved Accord Healthcare's gemcitabine injectable drug as an original application, providing a generic version of the anticancer agent gemcitabine.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Gemcitabine (Gemcitabine)

Snippet

ORIG AP for GEMCITABINE (GEMCITABINE)